Search

Rickey Hicks Phones & Addresses

  • Winterville, NC
  • Evans, GA
  • 1128 Bryson Dr, Greenville, NC 27834 (252) 756-7434
  • 111 Pine Ridge Cir, Starkville, MS 39759
  • 6110 Ozack Ct, Woodbridge, VA 22193
  • Germantown, MD
  • 1128 Bryson Dr, Greenville, NC 27834

Professional Records

Lawyers & Attorneys

Rickey Hicks Photo 1

Rickey Hicks - Lawyer

View page
ISLN:
911237564
Admitted:
1989

Medicine Doctors

Rickey Hicks Photo 2

Rickey L. Hicks

View page
Specialties:
Anatomic Pathology & Clinical Pathology
Work:
Tupelo Pathology Group
830 S Gloster St, Tupelo, MS 38801
(662) 377-3077 (phone), (662) 377-4883 (fax)
Education:
Medical School
University of Tennessee College of Medicine at Memphis
Graduated: 1982
Languages:
English
Description:
Dr. Hicks graduated from the University of Tennessee College of Medicine at Memphis in 1982. He works in Tupelo, MS and specializes in Anatomic Pathology & Clinical Pathology. Dr. Hicks is affiliated with North Mississippi Medical Center.

Public records

Vehicle Records

Rickey Hicks

View page
Address:
3809 Blue Spg Trce, Evans, GA 30809
VIN:
JTKDE167X70185058
Make:
SCION
Model:
TC
Year:
2007

Resumes

Resumes

Rickey Hicks Photo 3

Dean, College Of Science And Mathematics

View page
Location:
Evans, GA
Industry:
Higher Education
Work:
The Name of Georgia Regents University Has Been Changed To Augusta University
Dean, College of Science and Mathematics

East Carolina University Aug 2006 - Dec 2013
Department Chair

Walter Reed Army Institute of Research Jan 2001 - Aug 2006
Chief of Medicinal Chemistry

Mississippi State University Aug 1989 - Dec 2000
Associate Professor
Education:
Virginia Commonwealth University 1979 - 1984
Doctorates, Doctor of Philosophy, Philosophy, Organic Chemistry
Virginia Commonwealth University 1973 - 1977
Bachelors, Bachelor of Science, Chemistry
Skills:
Malaria
Cd Spectroscopy
Organic Chemistry
Natural Products
Peptides
Membranes
Antibacterial
Science
Cell Culture
Nmr Spectroscopy
Molecular Modeling
Medicinal Chemistry
Neuropeptides
Rickey Hicks Photo 4

Rickey Hicks

View page
Rickey Hicks Photo 5

Rickey Hicks

View page
Rickey Hicks Photo 6

Rickey Hicks

View page

Publications

Us Patents

Artemisinins With Improved Stability And Bioavailability For Therapeutic Drug Development And Application

View page
US Patent:
6951846, Oct 4, 2005
Filed:
Feb 27, 2003
Appl. No.:
10/376387
Inventors:
Mark G. Hartell - Laurel MD, US
Apurba K. Bhattacharjee - Silver Spring MD, US
Rickey P. Hicks - Woodbridge VA, US
John E. VanHamont - Fort Meade MD, US
Wilbur K. Milhous - Germantown MD, US
Assignee:
The United States of America as represented by the Secretary of the Army - Washington DC
International Classification:
C07D519/00
A61K031/357
US Classification:
514 58, 514 60, 514557, 5147722, 5147723, 514773, 514777, 514779, 514781, 514 54, 514895, 514 23, 426 96, 424440, 424493, 424500, 549348, 536103, 536120, 536122, 5361231
Abstract:
A stable form of artemisinin wherein an artelinic acid or artesunic acid is complexed with cyclodextrin analogs, preferably, β-cyclodextrin. The complexed cyclodextrin artemisinin formulation shields the peroxide portion of the artemisinin backbone from hydrolytic decomposition rendering it stable in solution. Artelinic acid and cyclodextrin are placed into contact with one another to yield a 2:1 molecular species. Artesunic acid and cyclodextrin yield a 1:1 molecular species. The complexed cyclodextrin artemisinin formulation is effective for the treatment of malaria and is stable in solution for long periods of time.

Artemisinins With Improved Stability And Bioavailability For Therapeutic Drug Development And Application

View page
US Patent:
7084132, Aug 1, 2006
Filed:
Apr 25, 2005
Appl. No.:
11/113546
Inventors:
Mark G. Hartell - Laurel MD, US
Apurba K. Bhattacharjee - Silver Spring MD, US
Rickey P. Hicks - Woodbridge VA, US
John E. VanHamont - Fort Meade MD, US
Wilbur K. Milhous - Germantown MD, US
Assignee:
The United States of America as represented by the Secretary of the Army - Washington DC
International Classification:
C07D 519/00
A61K 31/357
US Classification:
514 58, 514 60, 514557, 5147722, 5147723, 514773, 514777, 514779, 514 54, 514781, 514895, 514 23, 536103, 536120, 536122, 5361231, 424440, 424493, 424500
Abstract:
A stable form of artemisinin wherein an artelinic acid or artesunic acid is complexed with cyclodextrin analogs, preferably, β-cyclodextrin. The complexed cyclodextrin artemisinin formulation shields the peroxide portion of the artemisinin backbone from hydrolytic decomposition rendering it stable in solution. Artelinic acid and cyclodextrin are placed into contact with one another to yield a 2:1 molecular species. Artesunic acid and cyclodextrin yield a 1:1 molecular species. The complexed cyclodextrin artemisinin formulation is effective for the treatment of malaria and is stable in solution for long periods of time.

Antimalarial And Antiproliferative Pharmacophore Models, Novel Tryptanthrin Compounds Having Increased Solubility, And Methods Of Making And Using Thereof

View page
US Patent:
7259167, Aug 21, 2007
Filed:
Feb 7, 2003
Appl. No.:
10/359625
Inventors:
Daniel A. Nichols - Sparrows Point MD, US
Rickey P. Hicks - Woodbridge VA, US
Apurba K. Bhattacharjee - Silver Spring MD, US
Assignee:
United States of America as Represented by the Secretary of the Army - Washington DC
International Classification:
A61K 31/535
A01N 43/58
A01N 43/60
C07D 471/04
C07D 471/22
US Classification:
514257, 514256, 514250, 5142295
Abstract:
Disclosed herein is a pharmacophore model for antimalarial activity and methods of making and using thereof. The pharmacophore comprises two hydrogen bond acceptor (lipid) functions and two hydrophobic (aromatic) functions. The pharmacophore model was made using a test set of tryptanthrin compounds which exhibit antimalarial activity. Also disclosed are tryptanthrin compounds having greater solubility and bioactivity as compared to prior art tryptanthrin compounds and methods of making and using thereof. Also disclosed are methods of treating malaria in a subject.

Anti-Microbial Peptidomimetic Compounds And Methods To Calculate Anti-Microbial Activity

View page
US Patent:
8188033, May 29, 2012
Filed:
Dec 20, 2007
Appl. No.:
12/004397
Inventors:
Rickey P. Hicks - Greenville NC, US
Diva Karamenon Venugopal - Gaithersburg MD, US
Jayendra Bhonsle - Germantown MD, US
International Classification:
A61K 38/00
C07K 5/00
C07K 7/00
C07K 16/00
C07K 17/00
US Classification:
514 11, 530326
Abstract:
This invention encompasses synthetic antimicrobial peptide analogs having certain un-natural amino acids, including the un-natural amino acids hydrophobic tetrahydroisoquinolinecarboxylic acid (Tic) and octahydroindolecarboxylic acid (Oic), incorporated into the polypeptide backbone. These antimicrobial peptides (AMPs) are useful to treat infection in humans and other mammals of such bacteria as Gram positive bacteria, Gram negative bacteria and. Many of the AMPs also exhibit the property of reduced hemolytic activity. The invention also entails 3D-QSAR models and mathematical equations that calculate the biological activity of any peptide sequence against or.

Artemisinins With Improved Stability And Bioavailability For Therapeutic Drug Development And Application

View page
US Patent:
20060229279, Oct 12, 2006
Filed:
Jun 9, 2006
Appl. No.:
11/450009
Inventors:
Mark Hartell - Laurel MD, US
Apurba Bhattacharjee - Silver Spring MD, US
Rickey Hicks - Woodbridge VA, US
John VanHamont - Fort Meade MD, US
Wilbur Milhous - Germantown MD, US
International Classification:
A61K 31/724
A61K 31/335
US Classification:
514058000, 514452000
Abstract:
A stable form of artemisinin wherein an artelinic acid or artesunic acid is complexed with cyclodextrin analogs, preferably, β-cyclodextrin. The complexed cyclodextrin artemisinin formulation shields the peroxide portion of the artemisinin backbone from hydrolytic decomposition rendering it stable in solution. Artelinic acid and cyclodextrin are placed into contact with one another to yield a 2:1 molecular species. Artesunic acid and cyclodextrin yield a 1:1 molecular species. The complexed cyclodextrin artemisinin formulation is effective for the treatment of malaria and is stable in solution for long periods of time.

Novel Anti-Microbial Peptidomimetic Compounds And Methods To Calculate Anti-Microbial Activity

View page
US Patent:
20120197004, Aug 2, 2012
Filed:
Mar 20, 2012
Appl. No.:
13/424827
Inventors:
RICKEY P. HICKS - Greenville NC, US
Diva Karamenon Venugopal - Gaithersburg MD, US
Jayendra Bhonsle - Germantown MD, US
International Classification:
C07K 2/00
US Classification:
530300
Abstract:
This invention encompasses synthetic antimicrobial peptide analogs having certain un-natural amino acids, including the un-natural amino acids hydrophobic tetrahydroisoquinolinecarboxylic acid (Tic) and octahydroindolecarboxylic acid (Oic), incorporated into the polypeptide backbone. These antimicrobial peptides (AMPs) are useful to treat infection in humans and other mammals of such bacteria as Gram positive bacteria, Gram negative bacteria and . Many of the AMPs also exhibit the property of reduced hemolytic activity. The invention also entails 3D-QSAR models and mathematical equations that calculate the biological activity of any peptide sequence against or
Rickey P Hicks from Winterville, NCDeceased Get Report